[1]杨文波,张纳安,饶承龙,等.1例复发类鼻疽的病原学鉴定及生物学特性研究[J].陆军军医大学学报(原第三军医大学学报),2021,43(22):2441-2448.
 YANG Wenbo,ZHANG Na&rsquo,an,et al.Etiological identification and biological characteristics of recurrent melioidosis: report of 1 case[J].J Amry Med Univ (J Third Mil Med Univ),2021,43(22):2441-2448.
点击复制

1例复发类鼻疽的病原学鉴定及生物学特性研究(/HTML )
分享到:

陆军军医大学学报(原第三军医大学学报)[ISSN:1000-5404/CN:51-1095/R]

卷:
43卷
期数:
2021年第22期
页码:
2441-2448
栏目:
基础医学
出版日期:
2021-11-30

文章信息/Info

Title:
Etiological identification and biological characteristics of recurrent melioidosis: report of 1 case
作者:
杨文波张纳安饶承龙夏瑀培章美娟李骁闫晶敏陈海李倩毛旭虎
陆军军医大学(第三军医大学)药学与检验医学系临床微生物与免疫学教研室;华中农业大学生命科学技术学院;三亚市人民医院检验科
Author(s):
YANG Wenbo ZHANG Na’an RAO Chenglong XIA Yupei ZHANG Meijuan LI Xiao YAN Jingmin CHEN Hai LI Qian MAO Xuhu

Department of Clinical Microbiology and Immunology, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038; 2College of Life Science and Technology Huazhong Agricultural University, Wuhan, Hubei Province, 430070; 3Department of Clinical Laboratory Sanya People’s Hospital, Sanya, Hainan Province, 572000, China

关键词:
类鼻疽菌复发全基因组差异蛋白
Keywords:
Burkholderia pseudomallei recurrence whole genome differential protein
分类号:
R372; R378.99; R515.9
文献标志码:
A
摘要:

目的通过对1例复发类鼻疽进行系统病原学鉴定及生物学特性研究,分析和探讨类鼻疽菌长期滞留机体可能的适应宿主机制。方法对临床收集的来源于同一个患者时隔5年分离到的两株类鼻疽菌,进行微生物学鉴定、全基因组测序,并使用相关软件对测序数据进行多位点序列分型(multilocus sequence typing,MLST)、同源比对进化树、单核苷酸多态性(single nucleotide polymorphism,SNP)以及插入缺失(insertion-deletion,Indel)分析;进一步在感染肺上皮A549细胞模型中比较感染不同时间细胞内细菌载量变化;双向电泳-质谱技术分析两株细菌在蛋白水平的表达变化。结果分离到的两株类鼻疽菌,全基因组均约7.12 Mb,COG功能注释编码蛋白大致约5 000个;MLST分型均为ST58型;同源比对进化树分析显示它们位于同一分支且与其他分离自中国的类鼻疽菌亲缘关系较近;SNP/Indel分析显示复发株有114个SNP位点、55个Indel位点;与原发株相比,双向电泳-质谱结果表明复发株共有68个蛋白的表达水平发生了显著的变化;同时复发株感染A549后细胞内细菌载量明显增加(P<0.05)。结论以上复发菌株的基因组学、蛋白组学以及胞内感染增殖能力的系统研究提示类鼻疽菌可能在机体长期的选择压力下微进化,通过对细菌基因转录表达、分泌系统、耐药以及能量代谢等方面的调控更加适应其在宿主体内的生存而实现长期滞留。

Abstract:

ObjectiveTo analyze and explore the possible adaptive mechanisms that Burkholderia pseudomallei (B. pseudomallei) could long-term reside in the host cells based on the systematic etiological identification and biological characteristics of a patient with recurrent melioidosis. MethodsThe 2 B. pseudomallei strains isolated from the same patient at an interval of 5 years were performed for microbiological identification and genome sequencing, and the sequencing data were further analyzed by multilocus sequence typing (MLST), phylogenetic tree analysis of homologous alignment, single nucleotide polymorphism (SNP) analysis and insertion-deletion (Indel) analysis, respectively. Furthermore, the intracellular survival of the 2 clinical isolates of B. pseudomallei were examined at different times by counting the viable bacteria in the A549 cells. Two-dimensional electrophoresis (2-DE) and mass spectrometry was employed to analyze the protein expression of 2 strains of bacteria. ResultsThe 2 clinical isolates had a whole genome of about 7.12 Mb, and up about 5 000 Clusters of Orthologous Groups (COG) annotations, and was identified as sequence type (ST) 58 by MLST analysis. Phylogenetic analysis of homologous alignment showed that they were located in the same branch and were closely related to other B. pseudomallei isolates from China. SNP/Indel analysis indicated that there were 114 SNP sites and 55 Indel sites in the recurrent strain. The results of 2-DE displayed that the expression levels of 68 proteins in the recurrent strain were significantly changed compared with the primary strain. The intracellular bacterial load of recurrent strain was significantly increased compared to the primary strain in A549 cells(P<0.05). ConclusionBased on a series of studies with genomics, proteomics and ability of intracellular survival of the 2 clinical isolates of B. pseudomallei, the bacterium may evolve slightly under the long-term selective pressure of the organism, and adapt to the host environment for its own survival through the regulation of bacterial transcription, secretion system, drug resistance and energy metabolism.

参考文献/References:

[1]LIMMATHUROTSAKUL D, GOLDING N, DANCE D A B, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis[J]. Nat Microbiol, 2016, 1(1): 1-13. DOI: 10.1038/nmicrobiol.2015.8.
 
[2]WIERSINGA W J, VIRK H S, TORRES A G, et al. Limmathurotsakul D:  Melioidosis[J]. Nat Rev Dis Primers, 2018, 4: 17107. DOI:10.1038/nrdp.2017.107.
 
[3]PEACOCK SJ. Melioidosis[J]. Curr Opin Infect Dis, 2006, 19(5): 421-428.DOI:  10.1097/01.qco.0000244046.31135.b3.
 
[4]SCHMIDT I H E, GILDHORN C, BNING M A L, et al. Burkholderia pseudomallei modulates host iron homeostasis to facilitate iron availability and intracellular survival[J]. PLoS Negl Trop Dis 2018, 12(1): e0006096. DOI: 10.1371/journal.pntd.0006096.
 
[5]RUSTAD T R, HARRELL M I, LIAO R, et al. The enduring hypoxic response of Mycobacterium tuberculosis[J]. PLoS ONE 2008, 3(1): e1502. DOI: 10.1371/journal.pone.0001502.
 
[6]ALLWOOD E M, DEVENISH R J, PRESCOTT M, et al. Strategies for intracellular survival of Burkholderia pseudomallei[J]. Front Microbiol, 2011, 2: 170.
 
[7]VANDER BROEK C W, STEVENS J M.TYPE Ⅲ secretion in the melioidosis pathogen Burkholderia pseudomallei[J]. Front Cell Infect Microbiol, 2017, 7: 255. DOI:10.3389/fcimb.2017.00255.
 
[8]MUANGSOMBUT V, SUPARAK S, PUMIRAT P, et al.Inactivation of Burkholderia pseudomallei bsaQ results in decreased invasion efficiency and delayed escape of bacteria from endocytic vesicles[J]. Arch Microbiol 2008, 190(6): 623-631. DOI:10.1007/s00203-008-0413-3.
 
[9]BURTNICK M N, BRETT P J, NAIR V, et al. Burkholderia pseudomallei type Ⅲ secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages[J]. Infect Immun 2008, 76(7): 2991-3000. DOI:10.1128/IAI.00263-08.
 
[10]PILATZ S, BREITBACH K, HEIN N, et al. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence[J]. Infect Immun, 2006, 74(6):  3576-3586. DOI: 10.1128/iai.01262-05.
 
[11]KANG W T, VELLASAMY K M, CHUA E G, et al. Functional characterizations of effector protein BipC, a type Ⅲ secretion system protein, in Burkholderia pseudomallei pathogenesis[J]. J Infect Dis, 2015, 211(5): 827-834. DOI:10.1093/infdis/jiu492.
 
[12]SRINON V, MUANGMAN S, IMYAEM N, et al. Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant[J]. J Microbiol, 2013, 51(4):  522-526. DOI: 10.1007/s12275-013-2557-3.
 
[13]AUNKHAM A, SCHULTE A, WINTERHALTER M, et al.Porin involvement in cephalosporin and carbapenem resistance of Burkholderia pseudomallei[J]. PLoS ONE, 2014, 9(5): e95918. DOI:10.1371/journal.pone.0095918.
 
[14]RHOLL DA, PAPP-WALLACE KM, TOMARAS AP, et al. Molecular investigations of PenA-mediated beta-lactam resistance in Burkholderia pseudomallei[J]. Front Microbiol, 2011, 2: 139. DOI:10.3389/fmicb.2011.00139.
 
[15]PODNECKY N L, WUTHIEKANUN V, PEACOCK S J, et al. The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates[J]. Antimicrob Agents Chemother, 2013, 57(9):  4381-4386. DOI: 10.1128/aac.00660-13.
 
[16]CHANTRATITA N, RHOLL DA, SIM B, et al. Anti-microbial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei[J]. Proc Natl Acad Sci USA, 2011, 108(41): 17165-17170. DOI:10.2307/41321850.
 
[17]HAMAD MA, AUSTIN CR, STEWART AL, et al. Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei[J]. Antimicrob Agents Chemother, 2011, 55(7): 3313-3323. DOI:10.1128/AAC.00953-10.
 

相似文献/References:

[1]苏毅,赖思含,易海,等.异基因造血干细胞移植术治疗自体造血干细胞移植术后复发的恶性淋巴瘤17例效果分析[J].陆军军医大学学报(原第三军医大学学报),2012,34(24):2456.
 Su Yi,Lai Sihan,Yi Hai,et al.Allogeneic hematopoietic stem cell transplantation for recurrent lymphoma after autologous stem cell transplantation: clinical analysis of 17 cases[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(22):2456.
[2]唐鹏,姜军,杨新华,等.影响乳腺癌改良根治术后复发转移的临床病理因素分析[J].陆军军医大学学报(原第三军医大学学报),2007,29(11):1099.
 TANG Peng,JIANG Jun,YANG Xin-hua,et al.Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(22):1099.
[3]谢肇,吴雪晖,许建中.腰3椎体恶性骨巨细胞瘤快速复发1例[J].陆军军医大学学报(原第三军医大学学报),2007,29(09):845.
[4]王洪波,叶尔江·达哈尔,金格勒,等.脊柱结核术后复发因素的作用强度对比分析[J].陆军军医大学学报(原第三军医大学学报),2009,31(20):1955.
 WANG Hong-bo,YEERJIANG·Dahaer,JIN Ge-le,et al.Risk factors of postoperative recurrence of spinal tuberculosis: a comparative analysis on 486 cases[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(22):1955.
[5]胡非克,朱兵.儿童进行性骨化性肌炎1例[J].陆军军医大学学报(原第三军医大学学报),2008,30(16):1583.
[6]王颖,陈任安,李国辉,等.化疗联合微移植诱导治疗难治及复发急性髓系白血病疗效观察[J].陆军军医大学学报(原第三军医大学学报),2016,38(12):1347.
 Wang Ying,Chen Ren&rsquo,an,et al.Efficacy of micro transplantation induction combined with chemotherapy for refractory and relapsed acute myeloid leukemia[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(22):1347.
[7]徐磊,潘永全,何明忠,等.复发性实验性自身免疫性葡萄膜炎小鼠模型的诱导及其特点[J].陆军军医大学学报(原第三军医大学学报),2016,38(12):1432.
 Xu Lei,Pan Yongquan,He Mingzhong,et al.Induction and features of relapsing experimental autoimmune uveoretinitis in mice[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(22):1432.
[8]陈磊,高建国,张青云,等.腔内激光灼闭术治疗复发性下肢静脉曲张44例临床疗效分析[J].陆军军医大学学报(原第三军医大学学报),2014,36(03):297.
[9]袁婧,张长江,朱研,等.核苷(酸)类似物治疗乙型肝炎病毒相关肝病患者停药复发的临床转归及影响因素[J].陆军军医大学学报(原第三军医大学学报),2014,36(08):811.
 Yuan Jing,Zhang Changjiang,Zhu Yan,et al.Clinical outcome and impact factors of HBV-related patients’ relapse after nucleoside/nucleotide analogues withdrawal[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(22):811.
[10]郭华阳,周来新,刘斌,等.复发尖锐湿疣中人乳头瘤病毒基因的原位杂交法分型观察[J].陆军军医大学学报(原第三军医大学学报),1996,18(01):0.[doi:10.16016/j.1000-5404.1996.01.014 ]
 Guo Huayang,Zhou Laixin,Liu Bin,et al.[J].J Amry Med Univ (J Third Mil Med Univ),1996,18(22):0.[doi:10.16016/j.1000-5404.1996.01.014 ]

更新日期/Last Update: 2021-11-23